1834 Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

1834 Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	–	–	464
2020 Q4	$0	Hold	1	–	–	﹤0.01%	459
2020 Q3	$0	Hold	1	–	–	﹤0.01%	418
2020 Q2	$0	Hold	1	–	–	﹤0.01%	449
2020 Q1	$0	Hold	1	–	–	﹤0.01%	400
2019 Q4	$0	Hold	1	–	–	﹤0.01%	452
2019 Q3	$0	Hold	1	–	–	﹤0.01%	457
2019 Q2	$0	Hold	1	–	–	﹤0.01%	430
2019 Q1	$0	Hold	1	–	–	﹤0.01%	410
2018 Q4	$0	Hold	1	–	–	﹤0.01%	404
2018 Q3	$0	Hold	1	–	–	﹤0.01%	400
2018 Q2	$0	Sell	1 -1	-50%	-$62	﹤0.01%	417
2018 Q1	$0	Hold	2	–	–	﹤0.01%	444
2017 Q4	$0	Buy	+2	New	+$124	﹤0.01%	454

Other funds holding ANIP

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.66B AUM 6.69% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return